{"Clinical Trial ID": "NCT02176083", "Intervention": ["INTERVENTION 1:", "Intervention", "Text message management prompts: YBCS will receive text message invitations on how to manage hot flashes and vaginal dryness", "Invites to manage text messages", "INTERVENTION 2:", "Monitoring", "\u2022 Control YBCS will not receive text message prompts on managing hot flashes and vaginal dryness"], "Eligibility": ["Incorporation criteria:", "Breast cancer", "Women", "Completion of primary breast cancer treatment", "Age <=45"], "Results": ["Performance measures:", "Frequency of hot flashes", "Median number of daily hot flashes during week 4 of study", "Time limit: 1 week", "Results 1:", "Title of the arm/group: Intervention", "Description of the arm/group: Text message management invitations: YBCS will receive text message invitations on how to manage hot flashes and vaginal dryness", "Invites to manage text messages", "Total number of participants analysed: 11", "Median (interquartile range)", "Unit of measurement: daily hot flashes 2.2 (1.2 to 3.6)", "Results 2:", "Title of the arm/group: Control", "Description of the arm/group: YBCS Control will not receive text message prompts on managing flushes of vaginal heat and dryness", "Total number of participants analysed: 27", "Median (interquartile range)", "Unit of measurement: daily hot flashes 1.4 (0.7 to 2.3)"], "Adverse Events": ["Undesirable Events 1:", "Total: 0/11 (0.00 per cent)", "Adverse Events 2:", "Total: 0/27 (0.00 per cent)"]}